What Do PI-RADS Scores Mean?

The short answer: PI-RADS (Prostate Imaging Reporting and Data System) is a 1-to-5 scoring system radiologists use to describe how likely it is that a prostate MRI shows clinically significant prostate cancer. Scores of 1–2 mean cancer is unlikely, 3 is uncertain, and 4–5 mean cancer is likely to highly likely. Your urologist uses the score — along with your PSA, history, and risk factors — to decide what should happen next.

What is PI-RADS?

PI-RADS — short for Prostate Imaging Reporting and Data System — is the standard scoring system radiologists use to report what a prostate MRI shows. As they read your scan, they examine any suspicious areas (lesions) and assign each one a score from 1 to 5 based on how it appears on the different MRI sequences. Think of it as a forecast for the likelihood of significant cancer: the higher the number, the stronger the evidence. Because every radiologist uses the same system (currently PI-RADS version 2.1), your score means the same thing no matter where your MRI was done.

What does each PI-RADS score mean?

Each score describes how likely it is that the area seen on the MRI is clinically significant prostate cancer:

• PI-RADS 1 — Very low. Clinically significant cancer is highly unlikely.

• PI-RADS 2 — Low. Clinically significant cancer is unlikely.

• PI-RADS 3 — Intermediate. It’s genuinely uncertain — the features could go either way.

• PI-RADS 4 — High. Clinically significant cancer is likely.

• PI-RADS 5 — Very high. Clinically significant cancer is highly likely.

What does “clinically significant” mean?

Not all prostate cancers behave the same way. Some are slow-growing and low-grade — they may never grow, spread, or cause symptoms in a man’s lifetime. Others are more aggressive and do need treatment. When radiologists and urologists say “clinically significant,” they mean the kind of cancer that matters: one that is more likely to grow and cause harm if it isn’t found and treated. The PI-RADS system is designed to flag that kind of cancer — and to avoid turning up the small, quiet cancers that can often be safely watched instead of treated right away. (In technical terms, that’s usually a tumor with a Gleason score of 7 or higher, also called Grade Group 2 or above.)

What happens after I get my PI-RADS score?

Your score doesn’t decide anything on its own — your urologist puts it in context with your PSA level and how it’s changed, your age and overall health, your family history and other risk factors, and whether you’ve had a biopsy before. From there, the conversation usually goes one of a few ways:

• Scores of 1–2 often mean no biopsy is needed right now; monitoring your PSA over time may be enough.

• A score of 3 is the gray zone — your urologist may suggest additional tests, like a prostate cancer biomarker test, watchful monitoring, or a biopsy, depending on the rest of your picture.

• Scores of 4–5 usually lead to a recommendation for a targeted biopsy of the suspicious area — often an MRI-fusion biopsy, which uses your MRI images to guide the needle precisely to the lesion.

Whatever the score, the next step is a conversation, not a verdict — and the decision is made together with your doctor.

The bottom line

• PI-RADS is a 1-to-5 score on your prostate MRI report that estimates the likelihood of clinically significant prostate cancer.

• Scores of 1–2 are reassuring; 3 is the gray zone; 4–5 mean a closer look — usually a targeted biopsy — is warranted.

• The score is a guide, not a diagnosis: only a biopsy can confirm whether cancer is present.

• Your urologist weighs the score alongside your PSA, history, and risk factors to decide the next step with you.

By Chad Ellimoottil, MD — urologist at Michigan Medicine specializing in prostate cancer detection.

Disclaimer: This information is for general educational purposes only and is not medical advice. Please consult a qualified healthcare professional about any medical condition, diagnosis, or treatment decision.